![COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases | SpringerLink COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-020-04759-2/MediaObjects/296_2020_4759_Fig1_HTML.png)
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases | SpringerLink
![Prevalence of hydroxychloroquine (Plaquenil) retinopathy higher than previously thought - Optometry Australia Prevalence of hydroxychloroquine (Plaquenil) retinopathy higher than previously thought - Optometry Australia](https://www.optometry.org.au/wp-content/uploads/National_news_images/2021/March/normal_plaquenilbullseyemac_camu-600x300-Image-Retina-Gallery.jpg)
Prevalence of hydroxychloroquine (Plaquenil) retinopathy higher than previously thought - Optometry Australia
![Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases | Advances in Rheumatology | Full Text Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases | Advances in Rheumatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42358-020-00134-8/MediaObjects/42358_2020_134_Fig3_HTML.png)